Immunodiagnostics Market By Product Type (Reagents, Instruments, Software and Services) , By Technology (Enzyme-linked immunosorbent assay, Chemiluminescence immunoassay, Fluorescent immunoassay, Radioimmunoassay, Others) By Application (Infectious diseas

Immunodiagnostics Market By Product Type (Reagents, Instruments, Software and Services) , By Technology (Enzyme-linked immunosorbent assay, Chemiluminescence immunoassay, Fluorescent immunoassay, Radioimmunoassay, Others) By Application (Infectious diseases, Oncology & endocrinology, Bone & mineral diseases, Autoimmunity disorders, Cardiac biomarkers, Drug monitoring, Others) By End-user (Hospitals, Clinical Laboratories, Academic & research institutes, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

The immunodiagnostics market was valued at $24.2 billion in 2023, and is projected to reach $36.4 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.
Immunodiagnostics are tests that involve the use of antigen-antibody responses to identify, target, and eliminate pathogens or foreign substances. It serves as a powerful technique to detect a wide range of targets and thus finds its major application in the fields of infectious diseases and autoimmune disease detection, food safety, and cancer diagnostics. The most common Immunodiagnostics techniques include enzyme-linked immunosorbent assay (ELISA), radioimmunoassays, fluorescent immunoassays, and lateral flow assays.
The growth of the global immunodiagnostics market is majorly driven by alarming increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal disorders, and other chronic diseases due to vulnerability of geriatric population to such diseases and changes in lifestyle. Furthermore, increase in environmental pollution and rise in incidence of diseases due to high exposure to pollution have boosted the demand for immunodiagnostics. Immunodiagnostic tools play a key role in detecting environmental contaminants such as dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCB), explosives, organophosphorus pesticides, and biological warfare materials. In addition, contaminants in food such as Staphylococcal enterotoxin B as well as pesticides in fruits, vegetables, and grains can be easily detected using immunodiagnostics. However, high costs associated with immunodiagnostics and reluctance in the adoption of advanced technologies in emerging economies are expected to hamper the growth of the market. On the contrary, increase in awareness about advanced preventative health measures and technologically advancements in diagnostic kits, assays, and analyzers are expected to offer remunerative opportunities for the expansion of the global immunodiagnostics market during the forecast period.
The global immunodiagnostics market is segmented into product type, technology, application, end user, and region. Depending on product type, the market is classified into reagents, instruments, and software & services.As per technology, it is segregated into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, and others. Depending on application, it is fragmented into infectious diseases, oncology & endocrinology, bone & mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and others. By end user, it is categorized into hospitals, clinical laboratories, academic & research institutes, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the reagents segment is expected to lead the market by 2033.
As per technology, the ELISA technology segment dominated the immunodiagnostics market in 2023.
Depending on application, the infectious disease segment is likely to dominate the market during the forecast period.
By end user, the clinical laboratories segment is likely to be lucrative during the forecast period.
Region wise, North America was the major revenue generator in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global immunodiagnostics market include Abbott, Becton Dickinson, Agilent Technologies, Inc., Exact Sciences Corporation, Guardant Health, Illumina, Inc., Diaosorin, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Key Market Segments

By Product Type

Reagents
Instruments
Software and Services

By Technology

Enzyme-linked immunosorbent assay
Chemiluminescence immunoassay
Fluorescent immunoassay
Radioimmunoassay
Others

By Application

Infectious diseases
Oncology endocrinology
Bone mineral diseases
Autoimmunity disorders
Cardiac biomarkers
Drug monitoring
Others

By End-user

Hospitals
Clinical Laboratories
Academic research institutes
Others

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Abbott
Becton Dickinson
Agilent Technologies, Inc.
Exact Sciences Corporation
Guardant Health
Illumina, Inc.
Diaosorin
NeoGenomics Laboratories
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific Inc.